ANGLE plc (LON:AGL – Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 9.06 ($0.11) and traded as high as GBX 13.33 ($0.17). ANGLE shares last traded at GBX 12.50 ($0.16), with a volume of 4,330,772 shares traded.
Analysts Set New Price Targets
Separately, Berenberg Bank restated a “buy” rating and set a GBX 70 ($0.89) price target on shares of ANGLE in a research report on Thursday, September 26th.
View Our Latest Stock Analysis on AGL
ANGLE Stock Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- Energy and Oil Stocks Explained
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Applied Materials Market Capitulates: Now is the Time to Buy
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.